BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsuji N, Agbor-Enoh S. Cell-free DNA beyond a biomarker for rejection: Biological trigger of tissue injury and potential therapeutics. J Heart Lung Transplant 2021;40:405-13. [PMID: 33926787 DOI: 10.1016/j.healun.2021.03.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Verleden SE, Verleden GM. Novel biomarkers of chronic lung allograft dysfunction: is there anything reliable? Curr Opin Organ Transplant 2022;27:1-6. [PMID: 34939958 DOI: 10.1097/MOT.0000000000000944] [Reference Citation Analysis]
2 Rosenheck JP, Ross DJ, Botros M, Wong A, Sternberg J, Chen Y, Liang N, Baer A, Ahmed E, Swenerton R, Zimmermann BG, Fehringer G, Demko ZP, Olymbios M, Billings PR, Keller BC. Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant. Transplantation Direct 2022;8:e1317. [DOI: 10.1097/txd.0000000000001317] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Qian X, Shah P, Agbor-Enoh S. Noninvasive biomarkers in heart transplant: 2020-2021 year in review. Curr Opin Organ Transplant 2022;27:7-14. [PMID: 34939959 DOI: 10.1097/MOT.0000000000000945] [Reference Citation Analysis]
4 Kamath M, Shekhtman G, Grogan T, Hickey MJ, Silacheva I, Shah KS, Shah KS, Hairapetian A, Gonzalez D, Godoy G, Reed EF, Elashoff D, Bondar G, Deng MC. Variability in Donor-Derived Cell-Free DNA Scores to Predict Mortality in Heart Transplant Recipients – A Proof-of-Concept Study. Front Immunol 2022;13:825108. [DOI: 10.3389/fimmu.2022.825108] [Reference Citation Analysis]
5 Schneck E, Askevold I, Rath R, Hecker A, Reichert M, Guth S, Koch C, Sander M, Seeger W, Mayer K, Padberg W, Sommer N, Kuhnert S, Hecker M. Chronic Lung Allograft Dysfunction Is Associated with Increased Levels of Cell-Free Mitochondrial DNA in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. J Clin Med 2022;11:4142. [PMID: 35887906 DOI: 10.3390/jcm11144142] [Reference Citation Analysis]
6 Keller M, Agbor-Enoh S. Cell-free DNA in lung transplantation: research tool or clinical workhorse? Curr Opin Organ Transplant 2022;27:177-83. [PMID: 35649108 DOI: 10.1097/MOT.0000000000000979] [Reference Citation Analysis]
7 Jaksch P, Görzer I, Puchhammer-Stöckl E, Bond G. Integrated Immunologic Monitoring in Solid Organ Transplantation: the Road Towards Torque Teno Virus-guided Immunosuppression. Transplantation 2022. [PMID: 35509090 DOI: 10.1097/TP.0000000000004153] [Reference Citation Analysis]
8 Zangwill SD, Deshpande SR, Simpson PM, Liang HL, Zhang L, Dasgupta M, Richmond ME, Kindel SJ, Bichell DP, Mahle WT, Wigger MA, Schroder JN, Knecht KR, Pahl E, Gaglianello NA, North PE, Tomita-Mitchell A, Mitchell ME. Increase in nuclear cell-free DNA is associated with major adverse events in adult and pediatric heart transplant recipients. Clin Transplant 2021;:e14509. [PMID: 34649304 DOI: 10.1111/ctr.14509] [Reference Citation Analysis]
9 Feingold B, Rose-Felker K, West SC, Zinn MD, Berman P, Moninger A, Huston A, Stinner B, Xu Q, Zeevi A, Miller SA. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation. Pediatr Transplant 2021;:e14124. [PMID: 34420244 DOI: 10.1111/petr.14124] [Reference Citation Analysis]
10 Shah P, Agbor-Enoh S, Tunc I, Hsu S, Russell S, Feller E, Shah K, Rodrigo ME, Najjar SS, Kong H, Pirooznia M, Fideli U, Bikineyeva A, Marishta A, Bhatti K, Yang Y, Mutebi C, Yu K, Kyoo Jang M, Marboe C, Berry GJ, Valantine HA; GRAfT (Genomic Research Alliance for Transplantation) Investigators. Response by Shah et al to Letter Regarding Article, "Cell-Free DNA to Detect Heart Allograft Acute Rejection". Circulation 2021;144:e198-9. [PMID: 34491771 DOI: 10.1161/CIRCULATIONAHA.121.055697] [Reference Citation Analysis]